Krupa Mariusz, Moskała Marek, Składzień Tomasz, Grzywna Ewelina
Z Kliniki Neurotraumatologii CM UJ w Krakowie.
Przegl Lek. 2009;66(7):403-5.
In recent years in the Department of Neurotraumatology in Cracow it has been noticed the frequent connection between appearance of chronic subdural hematoma (CSDH) and treatment by anticoagulant medications. The aim of this study is to draw attention to the problem of insufficient control of anticoagulants consumption, especially by patients treated for cardiovascular system diseases that increases the risk of bleeding and CSDH development. The paper is based on data from questionnaires that was sent to patients with CSDH, cured in the Department of Neurotraumatology form 2004 to 2005. Analyzed was the group of 51 patients with chronic subdural hematoma; 37 individuals (72.5%) confirmed taking acetylsalicylic acid in the period of 3 months before admission to the Department, 9 (17.6%) patients answered that they were taking low-molecular weight heparin. One patient (1.9%) was taking chronically derivative of cumarin. The authors would inform that anticoagulant treatment might favour increase of chronic subdural hematoma incidence. It's especially important, because the average life expectancy has been prolonged in Poland and there are more people taking acetylsalicylic acid. This can be an epidemiological problem in future.
近年来，在克拉科夫的神经创伤科，人们注意到慢性硬膜下血肿（CSDH）的出现与抗凝药物治疗之间存在频繁关联。本研究的目的是引起人们对抗凝药物使用控制不足这一问题的关注，尤其是对于患有心血管系统疾病的患者，他们使用抗凝药物会增加出血风险和CSDH的发生风险。本文基于2004年至2005年期间发送给在神经创伤科治愈的CSDH患者的调查问卷数据。分析了51例慢性硬膜下血肿患者组成的群体；37人（72.5%）确认在入院前3个月内服用过乙酰水杨酸，9名（17.6%）患者回答他们正在服用低分子量肝素。1名患者（1.9%）长期服用香豆素衍生物。作者想要告知大家，抗凝治疗可能会促使慢性硬膜下血肿发病率增加。这一点尤为重要，因为在波兰人均预期寿命延长，服用乙酰水杨酸的人数增多。这在未来可能会成为一个流行病学问题。
